Selecting the optimal method for assessment of hypertension-mediated organ damage: a personalized approach - Top-Institutions - MDSpire

Selecting the optimal method for assessment of hypertension-mediated organ damage: a personalized approach

  • By

  • Eva Gerdts

  • Athanase Benetos

  • Rosa Maria Bruno

  • Gregory Y H Lip

  • Helga Midtbø

  • Maria Lorenza Muiesan

  • Victor Aboyans

  • Gianfranco Parati

  • January 28, 2026

  • 0 min

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Cardiology
    • Hypertension
    • Nephrology

  • #2

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Cardiology
    • Hypertension
    • Vascular Medicine

  • #3

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Cardiology
    • Hypertension
    • Nephrology

  • #4

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Cardiology
    • Hypertension
    • Nephrology

  • #5

    European Society of Hypertension (Research Collaborations)
    European Society of Hypertension (Research Collaborations)

    Milan, Italy

    Key Differentiators

    • Hypertension
    • Cardiology
    • Epidemiology

Original Source(s)

Selecting the optimal method for assessment of hypertension-mediated organ damage: a personalized approach

  • by Eva Gerdts, Athanase Benetos, Rosa Maria Bruno, Gregory Y H Lip, Helga Midtbø, Maria Lorenza Muiesan, Victor Aboyans, Gianfranco Parati

  • January 28, 2026

Related Content

FDA Monthly Preview: Key June Decisions to Watch

Several FDA decisions across multiple specialties are expected this month.

Less Sitting in Pregnancy Tied to Lower Risk

Pregnant patients who sat less and moved more at light intensity had a lower risk of adverse outcomes in a prospective cohort study, but the findings do not prove causation.

Comorbidity sequence, sex, and APOE-genotype forecast Alzheimer's disease diagnosis